CinCor Pharma Inc (CINC)
Aktien-Chart
Earnings
Value bought
Letzte 90 Tage
Value sold
Letzte 90 Tage
Net insiders buying
Letzte 90 Tage
Trades (buy and sell)
Letzte 90 Tage
| Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion | Insider und/oder position |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Wert | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-02-27 | 2022-11-28 | V Verkauf | Nicht geschäftsführender Verwaltungsratsmitglied Large shareholder |
6.000
-100.0%
14,3285.920 USD |
6.000 -100.0% | 14,32 | 85.920 USD | |
| 2022-08-17 | 2022-08-15 | K Kauf | Large shareholder |
487.333
+inf%
30,0014.619.990 USD |
487.333 +inf% | 30,00 | 14.619.990 USD | |
| 2022-08-17 | 2022-08-15 | K Kauf | Large shareholder |
112.667
+2.9%
30,003.380.010 USD |
112.667 +2.9% | 30,00 | 3.380.010 USD | |
| 2022-08-17 | 2022-08-15 | K Kauf | Large shareholder |
133.333
+3.3%
30,003.999.990 USD |
133.333 +3.3% | 30,00 | 3.999.990 USD | |
| 2022-08-15 | 2022-08-11 | K Kauf |
GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Large shareholder |
83.000
+2.0%
30,002.490.000 USD |
83.000 +2.0% | 30,00 | 2.490.000 USD | |
| 2022-08-15 | 2022-08-11 | K Kauf |
Sofinnova Venture Partners X, L.P. Large shareholder |
500.000
+9.0%
30,0015.000.000 USD |
500.000 +9.0% | 30,00 | 15.000.000 USD | |
| 2022-08-15 | 2022-08-11 | K Kauf | Large shareholder |
83.000
+2.0%
30,002.490.000 USD |
83.000 +2.0% | 30,00 | 2.490.000 USD | |
| 2022-08-15 | 2022-08-11 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied Large shareholder |
6.000
+inf%
30,00180.000 USD |
6.000 +inf% | 30,00 | 180.000 USD | |
| 2022-08-15 | 2022-08-11 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied Large shareholder |
500.000
+9.0%
30,0015.000.000 USD |
500.000 +9.0% | 30,00 | 15.000.000 USD | |
| 2023-02-27 | 2022-06-10 | V Verkauf |
Chief Medical Officer Führungsperson |
6
-0.2%
15,2191 USD |
6 -0.2% | 15,21 | 91 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf |
EVP CFO & Chief BD Officer Führungsperson |
100
+inf%
16,001.600 USD |
100 +inf% | 16,00 | 1.600 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf |
Sofinnova Venture Partners X, L.P. Large shareholder |
325.000
+6.2%
16,005.200.000 USD |
325.000 +6.2% | 16,00 | 5.200.000 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied Large shareholder |
325.000
+6.2%
16,005.200.000 USD |
325.000 +6.2% | 16,00 | 5.200.000 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf | Large shareholder |
220.000
+5.7%
16,003.520.000 USD |
220.000 +5.7% | 16,00 | 3.520.000 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf | Large shareholder |
312.500
+170.0%
16,005.000.000 USD |
312.500 +170.0% | 16,00 | 5.000.000 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf | Large shareholder |
157.500
+4.3%
16,002.520.000 USD |
157.500 +4.3% | 16,00 | 2.520.000 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf |
GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Large shareholder |
1.700.000
+70.1%
16,0027.200.000 USD |
1.700.000 +70.1% | 16,00 | 27.200.000 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf |
Chief Executive Officer Geschäftsführender Verwaltungsratsmitglied |
12.500
+inf%
16,00200.000 USD |
12.500 +inf% | 16,00 | 200.000 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf |
Chief Operating Officer Führungsperson |
1.500
+inf%
16,0024.000 USD |
1.500 +inf% | 16,00 | 24.000 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf |
Chief Operating Officer Führungsperson |
750
+0.6%
16,0012.000 USD |
750 +0.6% | 16,00 | 12.000 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf |
EVP Clinical Development Führungsperson |
100
+inf%
16,001.600 USD |
100 +inf% | 16,00 | 1.600 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf |
EVP Clinical Development Führungsperson |
2.500
+inf%
16,0040.000 USD |
2.500 +inf% | 16,00 | 40.000 USD | |
| 2022-01-13 | 2022-01-11 | K Kauf | Large shareholder |
1.700.000
+70.1%
16,0027.200.000 USD |
1.700.000 +70.1% | 16,00 | 27.200.000 USD |